跳至主要内容
临床试验/NCT06222164
NCT06222164招募中不适用

The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research

Invivoscribe, Inc.1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2024年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
2,000
试验地点
1
主要终点
Enrollment

研究概览

简要总结

Acquire residual human specimens and/or samples from patient samples which were sent for testing at LabPMM, LLC for Clinical Research

详细描述

Residual specimen/sample collection study where peripheral blood (PB), bone marrow (BM), genomic (gDNA), and/or formalin-fixed paraffin-embedded tissue (FFPE) specimens/samples are obtained from patient samples sent to LabPMM, LLC for clinical testing. Samples may be used for Clinical Research at LabPMM, LLC or at partner institutions

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Specimen/sample, peripheral blood (PB), bone marrow (BM), genomic DNA (gDNA) and/or formalin-fixed paraffin-embedded tissue (FFPE) from patients whose specimens/samples have been sent to LabPMM for clinical testing
  • Donor Age ≥ 18 years

排除标准

  • Sample/specimen has been obtained from a third-party vendor with a Materials Transfer Agreement (MTA) on file with LabPMM
  • The specimens/samples have previously been enrolled in a clinical study

结局指标

主要结局

Enrollment

时间窗: 3 years

N=2000

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

The Use of Residual De-identified Specimens and/or... | 临床试验